Literature DB >> 19340443

Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss.

István Sziklai1, Tamás József Batta, Tamás Karosi.   

Abstract

Otosclerosis is an inflammatory disease associated with persistent measles virus (MV) infection of the otic capsule. The nature of sensorineural hearing loss (SNHL) related to otosclerosis can be due to the chronic TNF-alpha release from the foci. TNF-alpha enters the inner ear fluid spaces in histologically active stages of otosclerosis and may cause outer hair cell functional disorder and subsequent SNHL without morphological changes of the organ of Corti. On the contrary, non-otosclerotic stapes ankylosis being a non-inflammatory disease is not harmful for hair cells. Theoretically, SNHL should not associate to this type of stapes fixation. Stapes footplates (N = 248) were examined by hematoxylin-eosin staining and corresponding MV-, OPG- and TNF-alpha-specific RT-PCR. Anti-measles IgG levels of serum specimens were measured by ELISA. Preoperative audiological results were correlated with otosclerotic and non-otosclerotic histopathologies. Among patients with stapes fixation, we found 93 active and 67 inactive otosclerosis, and 88 non-otosclerotic stapes ankylosis. MV could only be detected in otosclerotic stapes footplates. Audiometry revealed bone conduction threshold elevation toward the high frequencies in otosclerotic patients, which was associated to the duration of hearing loss. OPG mRNA expression was significantly lower in the TNF-alpha positive specimens, which was independent from virus positivity. In about one-third of stapes fixations, the etiology is non-otosclerotic stapes ankylosis. Histologic otosclerosis exhibits a strong correlation with MV presence in the bone as a sign of persistent MV infection and related inflammation with TNF-alpha release. This causes SNHL in the function of time. Non-otosclerotic stapes fixations do not cause high-frequency SNHL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340443     DOI: 10.1007/s00405-009-0967-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  A novel therapeutic option in Cogan diseases? TNF-alpha blockers.

Authors:  M Fricker; A Baumann; F Wermelinger; P M Villiger; A Helbling
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

2.  Measles virus in otosclerosis and the specific immune response of the inner ear.

Authors:  W Arnold; H P Niedermeyer; N Lehn; W Neubert; H Höfler
Journal:  Acta Otolaryngol       Date:  1996-09       Impact factor: 1.494

3.  Audiometric analyses confirm a cochlear component, disproportional to age, in stapedial otosclerosis.

Authors:  Vedat Topsakal; Erik Fransen; Sébastien Schmerber; Frank Declau; Matthew Yung; Frans Gordts; Guy Van Camp; Paul Van de Heyning
Journal:  Otol Neurotol       Date:  2006-09       Impact factor: 2.311

4.  Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule.

Authors:  Andreas F Zehnder; Arthur G Kristiansen; Joe C Adams; Saumil N Merchant; Michael J McKenna
Journal:  Laryngoscope       Date:  2005-01       Impact factor: 3.325

5.  Two subgroups of stapes fixation: otosclerosis and pseudo-otosclerosis.

Authors:  Tamás Karosi; József Kónya; Mihály Petkó; László Z Szabó; József Pytel; József Jóri; István Sziklai
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

6.  Otosclerosis: a genetically heterogeneous disease involving at least three different genes.

Authors:  K Van Den Bogaert; P J Govaerts; E M R De Leenheer; I Schatteman; M Verstreken; W Chen; F Declau; C W R J Cremers; P H Van De Heyning; F E Offeciers; T Somers; R J H Smith; G Van Camp
Journal:  Bone       Date:  2002-04       Impact factor: 4.398

Review 7.  A review on the genetics of otosclerosis.

Authors:  I Moumoulidis; P Axon; D Baguley; E Reid
Journal:  Clin Otolaryngol       Date:  2007-08       Impact factor: 2.597

Review 8.  RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.

Authors:  Y Wittrant; S Théoleyre; C Chipoy; M Padrines; F Blanchard; D Heymann; F Rédini
Journal:  Biochim Biophys Acta       Date:  2004-09-20

9.  A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9.

Authors:  Insaf Bel Hadj Ali; Melissa Thys; Najeh Beltaief; Isabelle Schrauwen; Nele Hilgert; Kathleen Vanderstraeten; Nele Dieltjens; Emna Mnif; Slah Hachicha; Ghazi Besbes; Saïda Ben Arab; Guy Van Camp
Journal:  Hum Genet       Date:  2008-01-26       Impact factor: 4.132

10.  Bone conduction thresholds in patients with otosclerosis.

Authors:  E Vartiainen; S Karjalainen
Journal:  Am J Otolaryngol       Date:  1992 Jul-Aug       Impact factor: 1.808

View more
  13 in total

1.  No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan.

Authors:  Noritaka Komune; Mitsuru Ohashi; Nozomu Matsumoto; Takashi Kimitsuki; Shizuo Komune; Yusuke Yanagi
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Comparative analysis of preoperative diagnostic values of HRCT and CBCT in patients with histologically diagnosed otosclerotic stapes footplates.

Authors:  Péter Révész; Balázs Liktor; Bálint Liktor; István Sziklai; Imre Gerlinger; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-06       Impact factor: 2.503

3.  Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity.

Authors:  Tamás Karosi; Péter Csomor; Anita Szalmás; József Kónya; Mihály Petkó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

4.  Diagnostic value of cone-beam CT in histologically confirmed otosclerosis.

Authors:  Balázs Liktor; Péter Révész; Péter Csomor; Imre Gerlinger; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-19       Impact factor: 2.503

Review 5.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

6.  Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.

Authors:  Małgorzata Potocka-Bakłażec; Monika Sakowicz-Burkiewicz; Jerzy Kuczkowski; Tadeusz Pawełczyk; Czesław Stankiewicz; Wojciech Sierszeń; Zbigniew Jankowski; Jacek Buczny
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

7.  The association between hearing impairment and polymorphisms of genes encoding inflammatory mediators in Japanese aged population.

Authors:  Yasue Uchida; Saiko Sugiura; Hiromi Ueda; Tsutomu Nakashima; Fujiko Ando; Hiroshi Shimokata
Journal:  Immun Ageing       Date:  2014-11-26       Impact factor: 6.400

Review 8.  MicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants.

Authors:  Kedar N Prasad; Stephen C Bondy
Journal:  Front Cell Neurosci       Date:  2017-09-11       Impact factor: 5.505

9.  Oral seeding and niche-adaptation of middle ear biofilms in health.

Authors:  Joo-Young Lee; Kristin M Jacob; Kazem Kashefi; Gemma Reguera
Journal:  Biofilm       Date:  2021-01-06

10.  Potential mediators of diabetes-related hearing impairment in the U.S. population: National Health and Nutrition Examination Survey 1999-2004.

Authors:  Kathleen E Bainbridge; Yiling J Cheng; Catherine C Cowie
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.